LONDON and RALEIGH, N.C., June 26, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the...

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes it hard to breathe and is primarily caused by long-term exposure...

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...

Regeneron (REGN) gets positive CHMP recommendation for odronextamab for the treatment of adults with relapsed/refractory follicular lymphoma or...

Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of pulmonary hypertension (PH) and heart failure (HF), announced the...

LEADERS of some doctor organizations called on the Food and Drug Administration (FDA) to approve the 2nd generation dengue vaccine, as the country...

Eli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the...

The Estonian Prime Minister Kaja Kallas has been nominated as EU High Representative for Foreign Affairs and Security Policy by European state...

Novo Nordisk (NVO) declines as a late-stage study of its uncontrolled hypertension and advanced chronic kidney disease candidate, ocedurenone, fails...

Competitive: Regeneron: The Director of Corporate Communications (for Europe and Canada) will work in close collaboration with the Corporate Affairs...